Clive Smith Selected Research

rifamide

3/2002

Potential of rifamides to inhibit TNF-induced NF-kappaB activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clive Smith Research Topics

Disease

2	Infections 11/2021 - 04/2002
2	Tuberculosis (Tuberculoses) 11/2021 - 03/2002
2	Rheumatoid Arthritis 07/2003 - 01/2002
2	Necrosis 03/2002 - 01/2002
1	Sepsis (Septicemia) 03/2004
1	Neoplasms (Cancer) 12/2003
1	Breast Neoplasms (Breast Cancer) 12/2003
1	Pathologic Processes 02/2003
1	Lung Injury 04/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2002
1	Inflammation (Inflammations) 04/2002
1	Lung Diseases (Lung Disease) 04/2002

Drug/Important Bio-Agent (IBA)

5	NF-kappa B (NF-kB)IBA 03/2004 - 01/2002
4	CytokinesIBA 03/2004 - 01/2002
1	Pharmaceutical PreparationsIBA 11/2021
1	LipopolysaccharidesIBA 03/2004
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2004
1	Aromatase InhibitorsIBA 12/2003
1	beta-Galactosidase (Lactaid)IBA 12/2003
1	Estrogens (Estrogen)FDA Link 12/2003
1	Estrogen ReceptorsIBA 12/2003
1	Tamoxifen FDA LinkGeneric 12/2003
1	LigandsIBA 12/2003
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2003
1	Interleukin-6 (Interleukin 6)IBA 07/2003
1	Interleukin-8 (Interleukin 8)IBA 07/2003
1	Matrix Metalloproteinases (MMPs)IBA 07/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2003
1	I-kappa B KinaseIBA 07/2003
1	AntigensIBA 02/2003
1	ChemokinesIBA 04/2002
1	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 04/2002
1	IntegrinsIBA 04/2002
1	Tetradecanoylphorbol AcetateIBA 03/2002
1	rifamideIBA 03/2002

Therapy/Procedure

2	Therapeutics 12/2003 - 07/2003